Global import export Trade Lead board, Post Buy, Sell and Info Trade Leads for free. Sign in your account ,you can post your product on your showroom or post your trade leads to attract more traders, get more business opportunities.
Type your emailaddress below, and a new, temporary password will be sent directly to your mailbox.
Hepatitis A vaccine is a freeze-dried preparation made from the live attenuated strain of hepatitis A virus (HAV) grown in human diploid cell cultures. After cultivation, harvest, and extraction of the virus, the virus suspension is lyophilized after adding an appropriate stabilizer to make the vaccine. It is used to prevent hepatitis A.
The freeze-dried hepatitis A vaccine is a preparation made from the live attenuated strain of hepatitis A virus (HAV) grown in human diploid cell cultures. After cultivation, harvest and extraction of the virus, the virus suspension is lyophilized after adding an appropriate srabilizer to make the vaccine. It looks like a milky-white crisp cake and it turns into a clear liquid after reconstitution.
Active constituent: live attenuated Hepatitis A virus.
Subsidiary materials: All the components of subsidiary materials approved shall be listed.
Diluent: sterile water for injection.
1.0 ml of reconstituted vaccine per container. 1.0 ml per single human dose containing not less than 6.50lg CCID50 of live hepatitis A virus.
Advantages: 1.Accordance with the trend of biomedicine.
2. Convenient for storage and transportation.
3. The improvement of the stability of the vaccine,30-months of self life.
4. The extension of the validation.
5. More stable immune results
Results from the study group of National 95 Key Task Project:
l 100% safety for injection of live hepatitis A vaccine,freeze-dried
l 100% seroconversion rate after 2 dose injection
l 100% epidemiologic protective efficacy
l All of the products passed the national quality control
Established in 1992, Changchun Changsheng Life Sciences Ltd. is a national new high-tech enterprise engaging in the development, production and sales of human vaccines and is a private enterprise with the largest varieties and the most diversified product structures in the same industry nowadays. The company invested and held shares in Wuxi Sinosbio Co., Ltd in 2015 and listed in Shenzhen Stock Exchange in the same year. At present, its total assets is nearly 5 billion RMB and the company has over 1100 employees. The company adheres to the development purpose of "caring life and seeding health" and aims at research and development at first-class level both at home and abroad, sincerely providing a better protection for people`s health.
For registered Members only.
Keywords (seperated by comma)
Hepatitis A Virus
specification in description
Delivery Lead Time
Payment & Price Terms
Hepatitis A Virus,Ive Attenuated Strain of HAV,HAV Treatment For Human
Product Portfolio / Other Products
Detailed Company Introduction
FOB Price & Port
seeing in Inquiry
every one of ourOur Team represent the spirit of our company: Professional,driven, committed